Multiple Myeloma
News
Nanoparticle therapy active in B-cell malignancies
An experimental nanoparticle therapy has shown preclinical activity against a range of B-cell malignancies, researchers have reported. The...
News
England’s Cancer Drugs Fund raises concerns
Credit: Rhoda Baer Cancer patients in England are more likely to receive prescriptions for expensive drugs than patients in Wales, according to a...
News
Palliative chemo can have undesired outcomes
Credit: Rhoda Baer Palliative chemotherapy can negatively impact the end of life for terminally ill cancer patients, according to a paper...
News
Drugs get orphan designation for AML, MM
Credit: FDA The US Food and Drug Administration (FDA) has granted orphan designation for the histone deacetylase (HDAC) inhibitor pracinostat to...
News
Race, geography play role in MGUS incidence
showing multiple myeloma Blacks may be twice as likely as whites to develop multiple myeloma (MM) because they are more likely to have monoclonal...
News
Drug could enhance effects of chemo
Credit: Rhoda Baer The drug spironolactone could improve the efficacy of platinum-based chemotherapy by preventing tumor cell repair, according...
News
Study reveals potential target for mucositis, GVHD prevention
Results of preclinical research point to a possible way of preventing mucositis, graft-vs-host disease, and other disorders associated with...
News
Inhibitor shows preclinical promise in leukemia, MM
Credit: VCU The experimental drug dinaciclib could potentially improve the treatment of multiple myeloma (MM) and myeloid leukemias, according to...
News
Making K-Ras cancers druggable
Credit: PNAS New findings suggest drugs can effectively fight K-Ras-mutant cancers—if they have a little help. Experiments in human cancer cells...
News
Health Canada approves pomalidomide for MM
Credit: CDC Health Canada has approved pomalidomide (Pomalyst) for use in combination with dexamethasone to treat patients with relapsed or...
News
Unique protein found in MM patients
Credit: Rhoda Baer Researchers say they have discovered a bacterial protein that attaches to virtually any antibody and prevents it from binding...